Healthy Skepticism Library
Items published in 2005
There are 1256 items in the Healthy Skepticism Library that were published in 2005.
Page 9 of 13 pages ‹ First < 7 8 9 10 11 > Last ›
HSL4859
Sociedades Medicas-Cientificas miembros de la Asociacion de Sociedades Cientificas-Medicas de Chile.
[Recommendations to avoid conflicts of interest].
Rev Med Chil 2005 May; 133:(5):607-8
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872005000500015&lng=en&nrm=iso
HSL4949
Haurum J, Bregenholt S.
Recombinant polyclonal antibodies: therapeutic antibody technologies come full circle.
IDrugs 2005 May; 8:(5):404-9
HSL8797
Committee on Publication Ethics (COPE).
[Guidelines on good publication practice: the committe on publication ethics (COPE) report 2003].
Pro Fono 2005 May-Aug; 17:(2):264-70
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=16909537&query_hl=8&itool=pubmed_DocSum
HSL11295
Pentecost MJ.
Vioxx, radiology, and the Food and Drug Administration.
J Am Coll Radiol 2005 May; 2:(5):394-7
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17411841&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL1502
Morgan D, Kaufman M.
FDA Calls Efforts For Bayer Illegal: Lawmakers' Help for Drug Firm Tests Limits
The Washington Post 2005 Apr 30;
HSL19749
Parnell K
Sex drives drug sales and patient discussion
Australian Doctor 2005 Apr 29
www.australiandoctor.com.au
HSL1514
Ismail A.
Prescription for Power: Drug makers' lobbying army ensures their legislative dominance
The Center for Public Integrity 2005 Apr 28;
HSL1689
Kravitz RL, Epstein RM, Feldman MD, Franz CE, Azari R, Wilkes MS, Hinton L, Franks P.
Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial.
JAMA 2005 Apr 27; 293:(16):1995-2002
http://jama.ama-assn.org/cgi/content/full/293/16/1995
HSL14686
Procopio M.
The multiple outcomes bias in antidepressants research
Medical Hypotheses 2005 Apr 27; 65:(2):395-399
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WN2-4G1V67S-3&_user=10&_coverDate=12%2F31%2F2005&_rdoc=34&_fmt=high&_orig=browse&_srch=doc-info(%23toc%236950%232005%23999349997%23596828%23FLA%23display%23Volume)&_cdi=6950&_sort=d&_docanchor=&_ct=44&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=37fe41b4681d8d3bc5e4b145a9cd6e12
HSL1063
Vedantam S, Kaufman M.
Doctors Influenced By Mention Of Drug Ads
The Washington Post 2005 Apr 26
HSL1562
Friedman R.
Mix Math and Medicine and Create Confusion
The New York Times 2005 Apr 26;
HSL1595
Pringle E.
Bush-Backed Drug Marketing Schemes
The Sierra Time 2005 Apr 26;
HSL17388
DeNoon DJ
Study: Patients Who Ask Doc for Drugs Get Them
FOX News 2005 Apr 26
http://www.foxnews.com/story/0,2933,154697,00.html
HSL973
Barrett A, Carey J.
"Off-Label" Drugs: J&J Is Pushing The Envelope.
Business Week 2005 Apr 25
http://www.businessweek.com/magazine/content/05_17/b3930071_mz011.htm
HSL1513
Drinkard J.
Drugmakers go furthest to sway Congress
USA TODAY 2005 Apr 25
HSL1574
Berenson A.
Evidence in Vioxx Suits Shows Intervention by Merck Officials
The New York Times 2005 Apr 24;
HSL1090
Women and Health Protection researcher a finalist in Canadian Geographic Environment Awards
Women and Health Protection and the Canadian Women's Health Network 2005 Apr 23
HSL1573
Vesely R.
Medical group OKs ethics rules
San Gabriel Valley Tribune 2005 Apr 23;
HSL19953
Limprecht E
Warning to drug companies: cross the TGA and risk a fine
Australian Doctor 2005 Apr 22
http://www.australiandoctor.com.au/news/warning-to-drug-companies--cross-the-tga-and-risk-
HSL20083
Limprecht E
Critic prompts review of pharma ads
Australian Doctor 2005 Apr 226
http://www.australiandoctor.com.au/news/latest-news/critic-prompts-review-of-pharma-ads
HSL975
Boseley S.
US accused of trying to block abortion pills
The Guardian 2005 Apr 21
HSL971
Kowalczyk L.
FDA requests anticonvulsants be reexamined
The Boston Globe 2005 Apr 20
HSL974
Risk of death is linked with Natrecor
Newz.in 2005 Apr 20
HSL972
Drug May Raise Risk of Dying, Research Says
The Washignton Post 2005 Apr 19
HSL978
Brown D.
Establishing Proof: Some Fifty Years Ago a Baby-Blinding Epidemic Confounded Experts -- Until a Pioneering Study Conclusively Tied Cause and Effect, and Enshrined Clinical Trials in Medical Practice
The Washington Post 2005 Apr 19
HSL980
Kornblut A, Wilson D.
Beyond Balco: How One Pill Escaped the List of Controlled Steroids
The New York Times 2005 Apr 17
HSL981
Greve F.
Statistics on disease prevalence often inflated
Kansas City Star 2005 Apr 17
HSL968
Pollard R.
Lax system means killer drugs slip through
Sydney Morning Herald 2005 Apr 16
HSL965
Sullivan J.
Official fined for ethics breach: The state's top pharmacist plans to appeal a ruling that a pharmaceutical firm gave him cash and trips.
Philadelphia Inquirer 2005 Apr 15
HSL966
Moran M.
Zyprexa IM Caution Issued in Some Countries But Not U.S.
Psychiatric News 2005 Apr 15
HSL967
Jacklet B.
Drug firm makes editor's job a pain: A medical journal's article rejection sets off industrywide brouhaha
The Portland Tribune 2005 Apr 15
HSL984
Wilde-mathews A, Schaefer-muÑoz S.
Judge Overturns Ban on Ephedra, Roils FDA Policy
The Wall Street Journal 2005 Apr 15
HSL5323
Comments of Consumers Union before the Food and Drug Administration Science Board
: Food and Drug Administration 2005 Apr 15
http://www.fda.gov/ohrms/dockets/ac/05/slides/2005-4136OPH_02_01_Consumer's%20Union.pdf
HSL19826
Suanders C
Drug companies fined $100,000 over confusing packs
Australian Doctor 2005 Apr 15
http://www.australiandoctor.com.au
HSL20084
Taylor R
I hate adverts
Australian Doctor 2005 Apr 1531
HSL20085
Montgomery B, Mansfield PR
Thiazide, please
Australian Doctor 2005 Apr 1531
HSL970
BBC News.
GSK investors bring Paxil lawsuit
BBC News 2005 Apr 14
HSL982
Alonso-zaldivar R.
A Silicone Implant Gets Panel's OK
The LA Times 2005 Apr 14
HSL983
Pringle E
TeenScreen - Angel of Mercy or Pill-Pusher
www.OpEdNews.com 2005 Apr 14
HSL1557
Seminário Internacional discute a propaganda de medicamentos
2005 Apr 14
http://www.opas.org.br/medicamentos/index.cfm?ent=2&carregar=2&action=mostrar&codigo=136
HSL957
Mathews AW.
FDA Panel Backs Implant Restrictions
The Wall Street Journal 2005 Apr 13
HSL961
Santora M, Carey B.
Depressed? New York City Screens for People at Risk
The New York Times 2005 Apr 13
HSL1089
Hankin Joan.
Levitra® (vardenafil HCl) Tablets
FDA 2005 Apr 13
http://web.archive.org/web/20090118215108/http://www.fda.gov/cder/warn/2005/Levitra.pdf
HSL946
Stafford A, Davis M.
Threat to PBS and Medicare safety nets
The Financial Review 2005 Apr 12
HSL950
Schneemann K.
Health spending justified
The Australian 2005 Apr 12
HSL959
White M.
Tighter controls promised on drug claims: Pharmaceutical companies to be forced to publish details of side-effects
The Guardian 2005 Apr 12
HSL962
Carey E.
Cholesterol drug spending may soar: Guidelines say 27% more patients need statins But few benefits for low-risk patients, study says
The Toronto Star 2005 Apr 12
HSL963
Harris G.
Popular Drugs for Dementia Tied to Deaths
The New York Times 2005 Apr 12
HSL3791
Hoffer LJ, Mendelson J.
Clinical trials registry.
CMAJ 2005 Apr 12; 172:(8):980
HSL941
Faunce T.
Cashing in on our pharmaceutical expertise
The Canberra Times 2005 Apr 11
HSL944
Herper M.
Breast Implants, Bextra And Fair Disclosure
Forbes.com 2005 Apr 11
HSL947
Cunningham M.
300 deaths blamed on arthritis pill
The Herald Sun 2005 Apr 11
HSL948
Editorial .
The Price of NIH Credibility
THE LOS ANGELES TIMES 2005 Apr 11
HSL1091
FDA Talk Paper
FDA 2005 Apr 11
HSL16247
Holmes J
Total Recall
Four Corners : ABC (Australia) 2005
http://www.abc.net.au/4corners/content/2005/s1340327.htm
HSL686
Carlisle W.
What Went Wrong with Vioxx?
Radio National (Australian Broadcasting Commission) 2005 Apr 10
http://www.abc.net.au/rn/talks/bbing/stories/s1343699.htm
HSL964
Associated Press.
Pa. gov't pharmacist fined for ethics violations, ties to Pfizer
WKYT 2005 Apr 10
HSL969
Waters R.
Medicating Aliah: When state mental health officials fall under the influence of Big Pharma, the burden falls on captive patients. Like this 13-year-old girl.
Mother Jones 2005 Apr 10
HSL2668
Seniors and Drugs: Prescribed to death
CBC News Online 2005 Apr 10
http://www.cbc.ca/news/background/seniorsdrugs/index.html
HSL5302
Altman DG, Bland JM.
Treatment allocation by minimisation.
BMJ 2005 Apr 9; 330:(7495):843
http://bmj.bmjjournals.com/cgi/content/full/330/7495/843
HSL5590
Shann F.
Non-specific effects of vaccination: vaccines have non-specific (heterologous) effects.
BMJ 2005 Apr 9; 330:(7495):844
http://bmj.bmjjournals.com/cgi/content/full/330/7495/844
HSL938
Harris G.
F.D.A. Announces Strong Warnings for Painkillers
THE NEW YORK TIMES 2005 Apr 8
HSL939
Berenson A.
Pfizer Loses One Remedy for Its Slump
The New York Times 2005 Apr 8
HSL1099
Widow Fights Zoloft-Maker's Attempt to Throw Out Court Claim that Zoloft Caused Husband's Suicide: Minnesota Attorney General Argues For Her Right to Pursue Claim
Baum Hedlund 2005 Apr 8
HSL20149
Cole L
US pharma ads increase risk awareness
Medical Observer 2005 Apr 813
HSL942
Prnewswire .
New FDA Labeling for Pfizer's Celebrex and All Other NSAIDs to Reflect Similar Cardiovascular Profile: Pfizer Separately Agrees to Suspend Sales of Bextra Due to FDA Evaluation of Risks of Rare But Serious Skin Reactions
PRNewswire 2005 Apr 7
HSL1100
FDA announces series of changes to the class of marketed non-steriodal anti-inflammatory drugs (NSAIDs)
FDA 2005 Apr 7
HSL1558
Fenam -.
Especialistas criticam propagandas de medicamentos
: FENAM - Federacao Nacional dos Medicos 2005 Apr 7
HSL949
Unhealthy Ethics
The Washington Post 2005 Apr 6
HSL976
Kerr K.
Medicine or marketing?: Pfizer plan to sell Lipitor mixed with a second drug draws fire from some medical experts Dowling College
Newsday.com 2005 Apr 6
HSL1556
Agencia Nacional
Especialistas criticam propagandas de medicamentos
: Agencia Nacional de Vigilancia Saitaria 2005 Apr 6
http://www.anvisa.gov.br/divulga/noticias/2005/060405_6.htm
HSL951
Hensley S.
Follow The Money: Doctors, Drug Makers Too Cozy? New Guidelines Fuel the Debate
The Wall Street Journal 2005 Apr 5
HSL953
Hamilton D.
Silent Treatment How Genentech, Novartis Stifled A Promising Drug: Biotech Firm Tried to Pursue Peanut-Allergy Injection, But Contract Got in Way
THE WALL STREET JOURNAL 2005 Apr 5
HSL955
Meikle J.
NHS links with drug firms under scrutiny
The Guardian 2005 Apr 5
HSL1096
Revised Advisory Committee Structure
MHRA 2005 Apr 5
HSL1094
Response to Health Select Committee report
MHRA 2005 Apr 4
HSL935
Hinsliff G.
Drugs firms 'creating ills for every pill': Expensive new medicines are oversold when cheaper therapies or prevention would work better, say MPs
The Observer 2005 Apr 3
HSL3789
Komesaroff P.
Ethical issues in the relationships involving medicine and industry: evolving problems require evolving.
Intern Med J 2005 Apr 01; 35:(4):203-5
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3046&uid=15836496&db=pubmed&url=http://www.blackwell-synergy.com/openurl?genre=article&sid=nlm:pubmed&issn=1444-0903&date=2005&volume=35&issue=4&spage=203
HSL3793
Warren CS, Strauss J, Taska JL, Sullivan SJ.
Inspiring or dispiriting? The effect of diet commercials on snack food consumption in high school and college-aged women.
Int J Eat Disord 2005 Apr 01; 37:(3):266-70
http://www3.interscience.wiley.com/cgi-bin/abstract/110441236/ABSTRACT?CRETRY=1&SRETRY=0
HSL3794
Longstaff C, Thelwell C, Whitton C.
Regulatory frameworks in developing countries.
Nat Biotechnol 2005 Apr 01; 23:(4):413
http://www.nature.com/doifinder/10.1038/nbt0405-413a
HSL4549
Morgan S, Bassett KL, Wright JM, Yan L.
First-line first? Trends in thiazide prescribing for hypertensive seniors
PLoS Med 2005 Apr 00; 2:(4):
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=15839739
HSL4991
Cockburn R, Newton PN, Agyarko EK, Akunyili D, White NJ.
The global threat of counterfeit drugs: why industry and governments must communicate the dangers.
PLoS Med 2005 Apr 01; 2:(4):e100
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0020100
HSL5156
Manchester A.
Counterfeit medicines kill.
Nurs N Z 2005 Apr 01; 11:(3):10
HSL5297
Allison JJ, Kiefe CI, Wall T, Casebeer L, Ray MN, Spettell CM, Hook EW 3rd, Oh MK, Person SD, Weissman NW.
Multicomponent Internet continuing medical education to promote chlamydia screening.
Am J Prev Med 2005 Apr 01; 28:(3):285-90
http://linkinghub.elsevier.com/retrieve/pii/S0749-3797(04)00366-6
HSL637
Mansfield PR, Vitry A.
Rofecoxib withdrawal.
Australian Prescriber 2005 Apr; 28:(2):30
http://www.australianprescriber.com/index.php?content=/magazines/vol28no2/28_33_letters.htm
HSL1600
Berliner N.
Customized Detailing through Physician Categorization
2005 Apr;
HSL1813
Stanley AG, Jackson D, Barnett DB.
The teaching of drug development to medical students: collaboration between the pharmaceutical industry and medical school.
Br J Clin Pharmacol 2005 Apr; 59:(4):464-74
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2125.2005.02374.x
HSL1826
Watson PY, Khandelwal AK, Musial JL, Buckley JD.
Resident and faculty perceptions of conflict of interest in medical education.
J Gen Intern Med 2005 Apr; 20:(4):357-9
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1525-1497.2005.04075.x
HSL2035
Kerridge I, Maguire J, Newby D, McNeill PM, Henry D, Hill S, Day R, Macdonald G, Stokes B, Henderson K.
Cooperative partnerships or conflict-of-interest? A national survey of interaction between the pharmaceutical industry and medical organizations.
Intern Med J 2005 Apr; 35:(4):206-10
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1444-0903.2004.00799.x
HSL2116
De Conno F, Ripamonti C, Brunelli C.
Opioid purchases and expenditure in nine western European countries: are we killing off morphine?
Palliat Med. 2005 Apr; 19:(3):179-84
http://www.ncbi.nlm.nih.gov/pubmed/15920930
HSL2275
Adair R, Callies L, Lageson J, Hanzel KL, Streitz SM, Gantert SC.
Posting guidelines: a practical and effective way to promote appropriate hypertension treatment.
Jt Comm J Qual Patient Saf 2005 Apr; 31:(4):227-32
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&DB=pubmed
HSL3746
Macias W, Lewis LS, Smith TL.
Health-related message boards/chat rooms on the Web: discussion content and implications for pharmaceutical sponsorships.
J Health Commun 2005 Apr-May; 10:(3):209-23
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3396&uid=16036729&db=pubmed&url=http://journalsonline.tandf.co.uk/Index/10.1080/10810730590934235
HSL3795
Dong X, Fetterolf D.
Specialty pharmacy: an emerging area of interest for medical management.
Dis Manag 2005 Apr; 8:(2):73-85
HSL4605
Faunce TS, Tomossy GF.
The UK House of Commons report on the influence of the pharmaceutical industry: lessons for equitable access to medicines in Australia.
Monash Bioeth Rev 2005 Apr; 24:(2):38-42
HSL9812
Figert AE.
Premenstrual syndrome as scientific and cultural artifact.
Integr Physiol Behav Sci 2005 Apr-Jun; 40:(2):102-13
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17393679&query_hl=12&itool=pubmed_DocSum
HSL11561
Doroshow J.
The role of the National Cancer Institute in drug development.
Clin Adv Hematol Oncol 2005 Apr; 3:(4):257-8
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=16166997
HSL15545
Agterberg R.
4th Annual Pharmaceutical Marketing Conference 'Marketing ROI for Pharma'
Journal of Medical Marketing 2005 Apr; 5:(2):182
http://www.palgrave-journals.com/jmm/journal/v5/n2/abs/5040226a.html
HSL16750
Ardati A, Stolley P, Knapp DE, Wolfe SM, Lurie P.
Statin-associated rhabdomyolysis.
Pharmacoepidemiol Drug Saf 2005 Apr; 14:(4):287
http://www3.interscience.wiley.com/journal/110432170/abstract?CRETRY=1&SRETRY=0
HSL1551
Burton R.
How Merck stacked the Vioxx deck
Salon.com 2005 Mar 31
HSL932
Metherell M.
Exposed: drugs price scandal
The Sydney Morning Herald 2005 Mar 30
Page 9 of 13 pages ‹ First < 7 8 9 10 11 > Last ›
